Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Revenue

Jiangsu CoWin Biotech had revenue of 65.07M CNY in the quarter ending September 30, 2026, with 24.06% growth. This brings the company's total for the last twelve months to 232.04M, up 38.81% year-over-year. In the year 2025, Jiangsu CoWin Biotech had annual revenue of 193.52M with 53.74% growth. That makes Jiangsu CoWin Biotech the 30,431st largest company in the world by revenue and 4,972nd in China.

• Revenue (ttm): 232.04M
• Revenue Growth: +38.81%
• P/S Ratio: 8.83
• Revenue / Employee: 316.99K
• Employees: 732
• Market Cap: 2.05B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Selling goods 114.94M 59.4%
• Services 78.48M 40.6%

By Geography

Chart

• China 179.15M 92.6%
• Foreign 14.27M 7.4%

Fiscal year ended Dec 31, 2025 See the full Jiangsu CoWin Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	193.52M	67.64M	53.74%
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error